| P2093 | author name string | Yudkin JS | |
| | Patterson DL | |
| | Gray RP | |
| P2860 | cites work | Myocardial infarct size and mortality in diabetic patients | Q36761010 |
| | Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi | Q36795285 |
| | Type 1 plasminogen activator inhibitor | Q38219810 |
| | Hyperglycaemia, diabetes and myocardial infarction | Q39481372 |
| | Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins | Q42836341 |
| | Estimation of Infarct Size in Man and its Relation to Prognosis | Q44019462 |
| | Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects | Q47212016 |
| | The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. | Q51614436 |
| | Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. | Q51631626 |
| | INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES | Q57951713 |
| | Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction | Q67245889 |
| | Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2 | Q67245916 |
| | Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates | Q67987029 |
| | Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction | Q67990124 |
| | Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus | Q69018082 |
| | Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications | Q69018269 |
| | Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response | Q69068473 |
| | Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction | Q69253415 |
| | Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin | Q69546015 |
| | Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction | Q69901572 |
| | Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction | Q69905443 |
| | The role of the fibrinolytic system in deep vein thrombosis | Q69939262 |
| | Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 |
| | Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction | Q70357354 |
| | Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction | Q71310542 |
| | Plasminogen activator release during venous stasis and exercise as determined by a new specific assay | Q72776870 |
| P433 | issue | 3 | |
| P921 | main subject | myocardial infarction | Q12152 |
| | risk factor | Q1475848 |
| | plasminogen | Q107129060 |
| P304 | page(s) | 228-232 | |
| P577 | publication date | 1993-03-01 | |
| P1433 | published in | British Heart Journal | Q26842435 |
| P1476 | title | Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients | |
| P478 | volume | 69 | |